Title: SENATE BILL 1064 By: Rosino
Official Title: SENATE BILL 1064 By: Rosino
Number of Sections: 13
Source: versions - Introduced
Media Type: application/pdf
Strikethrough Detection: 6 sections found

================================================================================

Section 1:
1
STATE OF OKLAHOMA
1
2
1st Session of the 60th Legislature (2025)
2
3
3
4
4
5
5
6
AS INTRODUCED
6
7
An Act relating to health insurance; amending 63 O.S.
7
2021, Section 7310, which relates to step therapy
8
protocol; establishing guidelines for step therapy
8
protocol; and providing an effective date.
9
9
10
10
11
11
12
BE IT ENACTED BY THE PEOPLE OF THE STATE OF OKLAHOMA:
12
13

Section 2:
SECTION 1. AMENDATORY 63 O.S. 2021, Section 7310, is
13
14
amended to read as follows:
14
15

Section 3:
Section 7310. A. As used in this section:
15
16

Section 4:
1. “Clinical practice guidelines” means a systematically
16
17
developed statement to assist decision-making by healthcare
17
18
providers and patients about appropriate healthcare or specific
18
19
clinical circumstances and conditions;
19
20

Section 5:
2. “Health insurance plan” means any individual or group health
20
21
insurance policy, medical service plan, contract, hospital service
21
22
corporation contract, hospital and medical service corporation
22
23
contract, fraternal benefit society or health maintenance
23
24
organization, municipal group-funded pool, the Oklahoma Medicaid
24
Req. No. 760 Page 1
1
Program and the state health care benefits plan that provides
1
2
medical, surgical or hospital expense coverage. For purposes of
2
3
this section, “health insurance plan” also includes any utilization
3
4
review organization that contracts with a health insurance plan
4
5
provider;
5
6

Section 6:
3. “Medical necessity” means that, under the applicable
6
7
standard of care, a health service or supply is appropriate to
7
8
improve or preserve health, life or function, to slow the
8
9
deterioration of health, life or function or for the early
9
10
screening, prevention, evaluation, diagnosis or treatment of a
10
11
disease, condition, illness or injury;
11
12

Section 7:
4. “Step therapy protocol” means a protocol or program that
12
13
establishes a specific sequence in which prescription drugs for a
13
14
specified medical condition that are medically appropriate for a
14
15
particular patient are covered by a health insurance plan;
15
16

Section 8:
5. “Step therapy exception” means a process by which a step
16
17
therapy protocol is overridden in favor of immediate coverage of the
17
18
healthcare provider’s selected prescription drug;
18
19

Section 9:
6. “Utilization review organization” means an entity that
19
20
conducts utilization review, not including a health insurance plan
20
21
provider performing utilization review for the provider’s own health
21
22
insurance plan; and
22
23
23
24
24
Req. No. 760 Page 2
1

Section 10:
7. “Pharmaceutical sample” means a unit of a prescription drug
1
2
that is not intended to be sold and is intended to promote the sale
2
3
of the drug.
3
4
B. For any health insurance plan that is delivered, issued for
4
5
delivery, amended or renewed on or after January 1, 2020, and that
5
6
utilizes a step therapy protocol, a health carrier, health benefit
6
7
plan or utilization review organization shall use recognized,
7
8
evidence-based and peer-reviewed clinical practice guidelines when
8
9
establishing any step therapy protocol, when such guidelines are
9
10
available. When peer-reviewed clinical guidelines are not
10
11
available, decisions shall default to the United States Food and
11
12
Drug Administration label as the authoritative reference.
12
13
C. 1. For any health insurance plan that is delivered, issued
13
14
for delivery, amended or renewed on or after January 1, 2020, and
14
15
that restricts coverage of a prescription drug for the treatment of
15
16
any medical condition pursuant to a step therapy protocol, the
16
17
health insurance plan provider shall provide to the prescribing
17
18
healthcare provider and patient access to a clear, convenient and
18
19
readily accessible process to request a step therapy exception. Any
19
20
health insurance plan provider that utilizes a step therapy protocol
20
21
shall make such process to request a step therapy exception
21
22
accessible on the health insurance plan provider’s website.
22
23

Section 11:
2. A health insurance plan shall grant a requested step therapy
23
24
exception if the submitted justification of the prescribing provider
24
Req. No. 760 Page 3
1
and supporting clinical documentation, if needed, is completed and
1
2
supports the statement of the provider that:
2
3
a. the required prescription drug is contraindicated or
3
4
will likely cause an adverse reaction or physical or
4
5
mental harm to the patient,
5
6
b. the required prescription drug is expected to be
6
7
ineffective based on the known clinical
7
8
characteristics of the patient and the known
8
9
characteristics of the prescription drug,
9
10
c. the patient has tried the required prescription drug
10
11
while under the patient’s current or a previous health
11
12
insurance plan and such prescription drug was
12
13
discontinued due to lack of efficacy or effectiveness,
13
14
diminished effect or an adverse event,
14
15
d. the required prescription drug is not in the best
15
16
interest of the patient, based on medical necessity,
16
17
or
17
18
e. the patient is stable on a prescription drug selected
18
19
by the patient’s healthcare provider for the medical
19
20
condition under consideration while on the patient’s
20
21
current or a previous health insurance plan.
21
22

Section 12:
3. A health insurance plan provider shall permit a patient to
22
23
appeal any decision rendered on a request for a step therapy
23
24
exception.
24
Req. No. 760 Page 4
1
D. A health insurance plan provider shall respond to a request
1
2
for a step therapy exception, or any appeal therefor, within
2
3
seventy-two (72) hours of receipt of the request or appeal. If a
3
4
patient’s prescribing healthcare provider indicates that exigent
4
5
circumstances exist, the health insurance plan provider shall
5
6
respond to such a request or appeal within twenty-four (24) hours of
6
7
receipt of the request or appeal. If the health insurance plan
7
8
provider fails to respond within the required time, the step therapy
8
9
exception or appeal shall be deemed granted. Upon granting a step
9
10
therapy exception, the health insurance plan provider shall
10
11
authorize coverage for and dispensation of the prescription drug
11
12
prescribed by the patient’s healthcare provider.
12
13
E. This section shall not be construed to prevent a healthcare
13
14
provider from prescribing a prescription drug that is determined to
14
15
be medically appropriate.
15
16
F. Nothing in this section shall be construed to authorize the
16
17
use of a pharmaceutical sample for the sole purpose of meeting the
17
18
requirements for a step therapy exception.
18
19
G. Nothing in this section shall be construed to prevent the
19
20
substitution of a drug in accordance with current statutes and
20
21
regulations of this state.
21
22
H. If the prescription drug that is subject to step therapy
22
23
protocol is approved by the FDA for the treatment of a rare disease
23
24
pursuant to Section 360bb of Title 21 of the United States Code, and
24
Req. No. 760 Page 5
1
no clinical practice guidelines are available for the rare disease,
1
2
any restrictions imposed by the step therapy protocol shall not be
2
3
any more restrictive than in accordance with the conditions of use
3
4
included in the FDA required labeling for the prescription drug.
4
5
I. The Oklahoma Insurance Department and the Oklahoma Health
5
6
Care Authority shall adopt rules necessary to implement and
6
7
administer this act prior to January 1, 2020.
7
8

Section 13:
SECTION 2. This act shall become effective November 1, 2025.
8
9
9
10
60-1-760 CAD 1/16/2025 3:02:42 PM
10
11
11
12
12
13
13
14
14
15
15
16
16
17
17
18
18
19
19
20
20
21
21
22
22
23
23
24
24
Req. No. 760 Page 6
[DELETED:  P B R]
[DELETED:  P]
[DELETED:  P]
[DELETED:  P t t t t t]
[DELETED:  P]
[DELETED:  P C 1]


================================================================================

Raw Text:
1
STATE OF OKLAHOMA
1
2
1st Session of the 60th Legislature (2025)
2
3
SENATE BILL 1064 By: Rosino
3
4
4
5
5
6
AS INTRODUCED
6
7
An Act relating to health insurance; amending 63 O.S.
7
2021, Section 7310, which relates to step therapy
8
protocol; establishing guidelines for step therapy
8
protocol; and providing an effective date.
9
9
10
10
11
11
12
BE IT ENACTED BY THE PEOPLE OF THE STATE OF OKLAHOMA:
12
13
SECTION 1. AMENDATORY 63 O.S. 2021, Section 7310, is
13
14
amended to read as follows:
14
15
Section 7310. A. As used in this section:
15
16
1. “Clinical practice guidelines” means a systematically
16
17
developed statement to assist decision-making by healthcare
17
18
providers and patients about appropriate healthcare or specific
18
19
clinical circumstances and conditions;
19
20
2. “Health insurance plan” means any individual or group health
20
21
insurance policy, medical service plan, contract, hospital service
21
22
corporation contract, hospital and medical service corporation
22
23
contract, fraternal benefit society or health maintenance
23
24
organization, municipal group-funded pool, the Oklahoma Medicaid
24
Req. No. 760 Page 1

1
Program and the state health care benefits plan that provides
1
2
medical, surgical or hospital expense coverage. For purposes of
2
3
this section, “health insurance plan” also includes any utilization
3
4
review organization that contracts with a health insurance plan
4
5
provider;
5
6
3. “Medical necessity” means that, under the applicable
6
7
standard of care, a health service or supply is appropriate to
7
8
improve or preserve health, life or function, to slow the
8
9
deterioration of health, life or function or for the early
9
10
screening, prevention, evaluation, diagnosis or treatment of a
10
11
disease, condition, illness or injury;
11
12
4. “Step therapy protocol” means a protocol or program that
12
13
establishes a specific sequence in which prescription drugs for a
13
14
specified medical condition that are medically appropriate for a
14
15
particular patient are covered by a health insurance plan;
15
16
5. “Step therapy exception” means a process by which a step
16
17
therapy protocol is overridden in favor of immediate coverage of the
17
18
healthcare provider’s selected prescription drug;
18
19
6. “Utilization review organization” means an entity that
19
20
conducts utilization review, not including a health insurance plan
20
21
provider performing utilization review for the provider’s own health
21
22
insurance plan; and
22
23
23
24
24
Req. No. 760 Page 2

1
7. “Pharmaceutical sample” means a unit of a prescription drug
1
2
that is not intended to be sold and is intended to promote the sale
2
3
of the drug.
3
4
B. For any health insurance plan that is delivered, issued for
4
5
delivery, amended or renewed on or after January 1, 2020, and that
5
6
utilizes a step therapy protocol, a health carrier, health benefit
6
7
plan or utilization review organization shall use recognized,
7
8
evidence-based and peer-reviewed clinical practice guidelines when
8
9
establishing any step therapy protocol, when such guidelines are
9
10
available. When peer-reviewed clinical guidelines are not
10
11
available, decisions shall default to the United States Food and
11
12
Drug Administration label as the authoritative reference.
12
13
C. 1. For any health insurance plan that is delivered, issued
13
14
for delivery, amended or renewed on or after January 1, 2020, and
14
15
that restricts coverage of a prescription drug for the treatment of
15
16
any medical condition pursuant to a step therapy protocol, the
16
17
health insurance plan provider shall provide to the prescribing
17
18
healthcare provider and patient access to a clear, convenient and
18
19
readily accessible process to request a step therapy exception. Any
19
20
health insurance plan provider that utilizes a step therapy protocol
20
21
shall make such process to request a step therapy exception
21
22
accessible on the health insurance plan provider’s website.
22
23
2. A health insurance plan shall grant a requested step therapy
23
24
exception if the submitted justification of the prescribing provider
24
Req. No. 760 Page 3

1
and supporting clinical documentation, if needed, is completed and
1
2
supports the statement of the provider that:
2
3
a. the required prescription drug is contraindicated or
3
4
will likely cause an adverse reaction or physical or
4
5
mental harm to the patient,
5
6
b. the required prescription drug is expected to be
6
7
ineffective based on the known clinical
7
8
characteristics of the patient and the known
8
9
characteristics of the prescription drug,
9
10
c. the patient has tried the required prescription drug
10
11
while under the patient’s current or a previous health
11
12
insurance plan and such prescription drug was
12
13
discontinued due to lack of efficacy or effectiveness,
13
14
diminished effect or an adverse event,
14
15
d. the required prescription drug is not in the best
15
16
interest of the patient, based on medical necessity,
16
17
or
17
18
e. the patient is stable on a prescription drug selected
18
19
by the patient’s healthcare provider for the medical
19
20
condition under consideration while on the patient’s
20
21
current or a previous health insurance plan.
21
22
3. A health insurance plan provider shall permit a patient to
22
23
appeal any decision rendered on a request for a step therapy
23
24
exception.
24
Req. No. 760 Page 4

1
D. A health insurance plan provider shall respond to a request
1
2
for a step therapy exception, or any appeal therefor, within
2
3
seventy-two (72) hours of receipt of the request or appeal. If a
3
4
patient’s prescribing healthcare provider indicates that exigent
4
5
circumstances exist, the health insurance plan provider shall
5
6
respond to such a request or appeal within twenty-four (24) hours of
6
7
receipt of the request or appeal. If the health insurance plan
7
8
provider fails to respond within the required time, the step therapy
8
9
exception or appeal shall be deemed granted. Upon granting a step
9
10
therapy exception, the health insurance plan provider shall
10
11
authorize coverage for and dispensation of the prescription drug
11
12
prescribed by the patient’s healthcare provider.
12
13
E. This section shall not be construed to prevent a healthcare
13
14
provider from prescribing a prescription drug that is determined to
14
15
be medically appropriate.
15
16
F. Nothing in this section shall be construed to authorize the
16
17
use of a pharmaceutical sample for the sole purpose of meeting the
17
18
requirements for a step therapy exception.
18
19
G. Nothing in this section shall be construed to prevent the
19
20
substitution of a drug in accordance with current statutes and
20
21
regulations of this state.
21
22
H. If the prescription drug that is subject to step therapy
22
23
protocol is approved by the FDA for the treatment of a rare disease
23
24
pursuant to Section 360bb of Title 21 of the United States Code, and
24
Req. No. 760 Page 5

1
no clinical practice guidelines are available for the rare disease,
1
2
any restrictions imposed by the step therapy protocol shall not be
2
3
any more restrictive than in accordance with the conditions of use
3
4
included in the FDA required labeling for the prescription drug.
4
5
I. The Oklahoma Insurance Department and the Oklahoma Health
5
6
Care Authority shall adopt rules necessary to implement and
6
7
administer this act prior to January 1, 2020.
7
8
SECTION 2. This act shall become effective November 1, 2025.
8
9
9
10
60-1-760 CAD 1/16/2025 3:02:42 PM
10
11
11
12
12
13
13
14
14
15
15
16
16
17
17
18
18
19
19
20
20
21
21
22
22
23
23
24
24
Req. No. 760 Page 6

[DELETED:  P B R]
[DELETED:  P]
[DELETED:  P]
[DELETED:  P t t t t t]
[DELETED:  P]
[DELETED:  P C 1]